Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 13/20 | 1.00 |
| ▸ | CNR1 | P21554 | 11/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.88 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.88 |
| ▸ | PPARG | P37231 | 4/20 | 0.59 |
| ▸ | PPARD | Q03181 | 4/20 | 0.59 |
| ▸ | PPARA | Q07869 | 4/20 | 0.59 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28661229 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL1030994 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL26127030 | 0.98 | CNR2 (0.97) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL4880981 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL1031361 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL30698242 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL30698241 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL1030239 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL4885154 | 0.92 | CNR2 (0.85) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL4878774 | 0.92 | CNR2 (0.85) | CNR2CNR1TRPA1TRPV1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3969163-B1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-2767174-B2 | Oral compositions | SYMRISE AG (DE) | 2020-07-01 | — | — | EP | claimed |
| EP-2767174-B1 | Oral compositions | SYMRISE AG (DE) | 2016-12-14 | — | — | EP | claimed |
| US-9468225-B2 | Oral compositions | SYMRISE AG (DE) | 2016-10-18 | — | — | US | claimed |
| EP-2058297-B1 | Use of alkamides for masking an unpleasant flavor | SYMRISE AG (DE) | 2015-05-20 | — | — | EP | claimed |
| US-20140234412-A1 | ORAL COMPOSITIONS | SYMRISE AG (DE) | 2014-08-21 | — | — | US | claimed |
| EP-2767174-A1 | Oral compositions | Symrise AG (DE) | 2014-08-20 | — | — | EP | claimed |
| EP-1977655-B1 | Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions | SYMRISE AG (DE) | 2011-05-18 | — | — | EP | claimed |
| EP-2008530-B1 | Aroma composition for reducing or suppressing unwanted bitter and astringent impressions | SYMRISE AG (DE) | 2011-01-19 | — | — | EP | claimed |
| US-20090124701-A1 | USE OF ALKAMIDES FOR MASKING AN UNPLEASANT FLAVOR | SYMRISE GMBH & CO. KG (DE) | 2009-05-14 | — | — | US | claimed |
| EP-2058297-A1 | Use of alkamides for masking an unpleasant flavor | Symrise GmbH & Co. KG (DE) | 2009-05-13 | — | — | EP | claimed |
| EP-2008530-A1 | Aroma composition for reducing or suppressing unwanted bitter and astringent impressions | Symrise GmbH & Co. KG (DE) | 2008-12-31 | — | — | EP | claimed |
| US-20080317923-A1 | AROMA COMPOSITION FOR REDUCING OR SUPPRESSING AN UNDESIRED BITTER, ASTRINGENT IMPRESSION | SYMRISE GMBH & CO. KG (DE) | 2008-12-25 | — | — | US | claimed |
| EP-1977655-A1 | Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions | Symrise GmbH & Co. KG (DE) | 2008-10-08 | — | — | EP | claimed |
| US-20080242740-A1 | AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS | SYMRISE GMBH & CO. KG (DE) | 2008-10-02 | — | — | US | claimed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-20240033703-A1 | Method for Producing Microcapsules | AG, SYMRISE (DE) | 2024-02-01 | — | — | US | disclosed |
| US-20080317923-A1 | AROMA COMPOSITION FOR REDUCING OR SUPPRESSING AN UNDESIRED BITTER, ASTRINGENT IMPRESSION | SYMRISE GMBH & CO. KG (DE) | 2008-12-25 | — | — | US | disclosed |
| EP-1977655-A1 | Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions | Symrise GmbH & Co. KG (DE) | 2008-10-08 | — | — | EP | disclosed |
| US-20080242740-A1 | AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS | SYMRISE GMBH & CO. KG (DE) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234412-A1 | ORAL COMPOSITIONS | FABP4, GPR119, FABP2 | CNR2 89/4885CNR1 262/4885TRPA1 516/4885 |
| US-20090124701-A1 | USE OF ALKAMIDES FOR MASKING AN UNPLEASANT FLAVOR | B3GNT2, NAA15, NAA40 | CNR2 793/4885CNR1 1791/4885TRPA1 287/4885 |
| US-20080242740-A1 | AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS | TAS2R5, TAS2R20, TAS2R40 | CNR2 723/4885CNR1 1264/4885TRPA1 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.